| Letter Released From FDA Fabricates
H1N1 Vaccine Safety and Effectiveness
The Food and Drug Administration (FDA) Commissioner has released
a letter to U.S. healthcare professionals which attempts to
restore confidence in the H1N1 vaccine, while making outlandish
claims on the vaccine's safety and effectiveness.
For clarity, bold faced excerpts of the Commissioner's letter
will be emphasized below. An explanation of each misrepresentation
of the facts will follow:
As this new infectious
disease sweeps through communities across the country, you must
juggle your usual patient care responsibilities with a special
role in influenza response. Delays in vaccine delivery and the
persistence of myths about vaccination have not made your job
any easier. Thank you for rising to this public health challenge.
The only delays in vaccine delivery have been caused by the deliberate
attempts by government to create artificial
scarcity and the usage of shortage
marketing techniques to foster a sense of urgency and panic.
It's similar to the "Hot Christmas Toy Phenomenon" where
toys are stocked to the max in a warehouse and toy companies create
scarcity so people frantically run to the store and take them
off the shelves.
The only myths portrayed by the mainstream media are actually
facts and vice-versa. Common myths that the media portrays
as facts are that flu vaccines prevent the flu, create immunity,
are non-toxic and proven safe and effective. All are complete
fallacies.
The Commissioner then goes through a ludicrous explanation to
justify how the 2009 H1N1 vaccine is made in an attempt to validate
the six month manufacture-to-delivery time frame:
Some of your patients may be asking how the FDA, the manufacturers,
and the scientific community can have confidence in vaccines that
were available just six months after the 2009 H1N1 virus emerged.
...scientists at laboratories in the United States and elsewhere
modified the 2009 H1N1 virus into a version suitable to be used
as the “seed” for the development of vaccines.... For
the 2009 H1N1 virus, modified strains suitable for vaccine manufacturing
were created and provided to influenza vaccine manufacturers by
late May.
...next step was to develop a tool to accurately measure the
amount of vaccine antigen that was being produced. Scientists
from the United States, United Kingdom, Australia, Japan, and
other nations, working together as part of the World Health Organization,
developed the reagents needed to assure the proper amount of antigen
goes into each dose of vaccine.
Anybody who has worked extensively in the vaccine industry can
attest to the minimum 3-5 year (sometimes 7-10) turnaround period
from initial manufacture and development to delivery. The modified
strains were NOT created and provided to vaccine manufacturers
in late May as the Commissioner suggests. The only way this vaccine
could have been produced this quickly, was if they knew about
it in 2006 or before. Well, IBM
knew about it, perhaps all the vaccine manufacturers did as
well. After all, Novartis'
patent application was in 2006.
As previously reported, the standard to test any vaccine is to
first produce exposure to the virus and subsequently prevent the
infection. This is the only scientifically established method
of concluding the efficacy of any vaccine. What the Commissioner
fails to address in her unscientific rhetoric, is that because
of the speedy regulatory approvals that were necessary to get
these pandemic vaccines on the shelf, it would have been virtually
impossible for any manufacturer or laboratory to effectively test
any of these H1N1 vaccines using this protocol. Influenza vaccines
(including H1N1) have actually never used the protocol to begin
with. Thus, every H1N1 vaccine manufactured and claimed to be
tested has been approved using scientific fraud!
In fact, most H1N1 vaccines trials are still ongoing and no conclusive
results have been generated for any of them. A simple search at
clinicaltrials.gov will
validate this fact.
We are not cutting any corners. Just
as for seasonal influenza vaccine, no lot of the 2009 H1N1 vaccine
can be used until it has been carefully evaluated and released
as sterile and potent by both the manufacturer and by the FDA.
In addition, the FDA and other agencies
are looking for any unexpected, rare, serious adverse events and
are quickly investigating concerns. We are also collaborating
with our global counterparts to share information and experience.
Should any safety concerns arise, we will evaluate them thoroughly
and bring them to the public’s attention quickly.
The entire U.S. population is being used as a giant experiment
with vaccines that have not even passed trials as evidenced through
inconclusive and ongoing trials.
How have they proven safety and effectiveness? How have they not
cut corners? How have they carefully evaluated the vaccine?
Every single ingredient in the H1N1 vaccine approved for use in
the U.S. from Sanofi-Pasteur,
Novartis,
MedImmune
to CSL
contain carcinogenic,
neurotoxin, immuntoxin and sterile agents. No pharmacokinetic
properties have been studied for any of these toxins and their
effects in any of the above "approved" H1N1 vaccines
is unknown according to all vaccine inserts.
It would be impossible to generate any more lies than are already
listed in this address to health professionals. The FDA Commissioner,
Margaret Hamburg, should revise her letter to at least contain
one truth because as it stands, this story makes Harry Potter
look factual.
Dave Mihalovic is a Naturopathic Doctor who specializes in
vaccine research, cancer prevention and a natural approach to
treatment.
Reference Source FDA.gov
November 13, 2009
 ...............................................................................................................
|
